← back to search

Luciane T. Kagohara

Bloomberg (United States) · US
🔎 Find collaborators in Immunology · Oncology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Immunology · Oncology
Research interest
Research interests include Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Phagocytosis and Immune Regulation, and Radiomics and Machine Learning in Medical Imaging.
h-index
23
citations
2,310
works
415
NIH funding
primary concept
Biology
email

Recent publications

Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
Nature Communications 2026cited by 4position: middledoi
Human interpretable grammar encodes multicellular systems biology models to democratize virtual cell laboratories
Cell 2025cited by 37position: middledoi
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Nature Medicine 2024cited by 209position: middledoi
Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma
Cancer Research 2024cited by 44position: middledoi
Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence
Genome Medicine 2023cited by 122position: lastdoi
From bench to bedside: Single-cell analysis for cancer immunotherapy
Cancer Cell 2021cited by 131position: lastdoi
Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection
OncoImmunology 2021cited by 18position: middledoi
Epigenetic regulation of gene expression in cancer: techniques, resources and analysis
Briefings in Functional Genomics 2017cited by 136position: firstdoi
Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
Nature Communications 2015cited by 148position: middledoi
The TGFβ–miR200–MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR Inhibitors
Cancer Research 2014cited by 126position: middledoi
PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
Cancer Immunology Research 2013cited by 375position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Elana J. Fertig · Genetic Resources Center5 papers (2015–2024)Elizabeth M. Jaffee · NYU Langone Health4 papers (2021–2024)David Sidransky · Mitra Biotech (India)3 papers (2013–2015)Mark Yarchoan · Molecular Oncology (United States)3 papers (2021–2024)Xiaofei Chang · East China University of Science and Technology2 papers (2014–2015)Atul Bedi · Johns Hopkins Medicine2 papers (2014–2015)Rajani Ravi · Johns Hopkins Medicine2 papers (2014–2015)Evgeny Izumchenko · University of Chicago2 papers (2014–2015)Robert A. Anders · University of Baltimore2 papers (2013–2023)Mohammad Obaidul Hoque · Johns Hopkins Medicine2 papers (2014–2015)Ludmila Danilova · Convergence2 papers (2017–2023)Won Jin Ho · Bloomberg (United States)2 papers (2021–2021)Genevieve Stein-O’Brien · Convergence2 papers (2017–2021)Mariana Brait · New York University2 papers (2014–2015)Atul Deshpande · Bloomberg (United States)2 papers (2021–2023)Reecha Suri · National Heart Lung and Blood Institute1 papers (2021–2021) · 1 papers (2021–2021)Brandon Luber · Johns Hopkins Medicine1 papers (2013–2013)Edward Gane · New Zealand Christians in Science1 papers (2024–2024)Samantha Guinn · Johns Hopkins Medicine1 papers (2021–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Immunology · Oncology →